A Double-Blind, Placebo-Controlled Study of the Use of Amphetamine in the Treatment of Aphasia
- 1 September 2001
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 32 (9), 2093-2098
- https://doi.org/10.1161/hs0901.095720
Abstract
Background and Purpose — A number of studies suggest that drugs which increase the release of norepinephrine promote recovery when administered late (days to weeks) after brain injury in animals. A small number of clinical studies have investigated the effects of the noradrenergic agonist dextroamphetamine in patients recovering from motor deficits following stroke. To determine whether these findings extend to communication deficits subsequent to stroke, we administered dextroamphetamine, paired with speech/language therapy, to patients with aphasia. Methods — In a prospective, double-blind study, 21 aphasic patients with an acute nonhemorrhagic infarction were randomly assigned to receive either 10 mg dextroamphetamine or a placebo. Patients were entered between days 16 and 45 after onset and were treated on a 3-day/4-day schedule for 10 sessions. Thirty minutes after drug/placebo administration, subjects received a 1-hour session of speech/language therapy. The Porch Index of Communicative Ability was used at baseline, at 1 week off the drug, and at 6 months after onset as the dependent language measure. Results — Although there were no differences between the drug and placebo groups before treatment ( P =0.807), by 1 week after the 10 drug treatments ended there was a significant difference in gain scores between the groups ( P =0.0153), with the greater gain in the dextroamphetamine group. The difference was still significant when corrected for initial aphasia severity and age. At the 6-month follow-up, the difference in gain scores between the groups had increased; however, the difference was not significant ( P =0.0482) after correction for multiple comparisons. Conclusions — Administration of dextroamphetamine paired with 10 1-hour sessions of speech/language therapy facilitated recovery from aphasia in a small group of patients in the subacute period after stroke. Neuromodulation with dextroamphetamine, and perhaps other drugs that increase central nervous system noradrenaline levels, may facilitate recovery when paired with focused behavioral treatment.Keywords
This publication has 18 references indexed in Scilit:
- Aphasia Treatment: A Key Issue for Research into the Twenty-First CenturyBrain and Language, 2000
- Mapping the Sensory MosaicScience, 1998
- Neuroscience and neurorehabilitation CommentaryCurrent Opinion in Neurology, 1994
- Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injuryPharmacology Biochemistry and Behavior, 1990
- Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patientsAnnals of Neurology, 1988
- The Changing View of Neural SpecificityScience, 1985
- Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablationBrain Research, 1985
- Somatosensory cortical map changes following digit amputation in adult monkeysJournal of Comparative Neurology, 1984
- Finger SpellingAcademic Therapy, 1982
- Amphetamine, Haloperidol, and Experience Interact to Affect Rate of Recovery After Motor Cortex InjuryScience, 1982